{"id":904154,"date":"2025-11-03T09:40:34","date_gmt":"2025-11-03T14:40:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/"},"modified":"2025-11-03T09:40:34","modified_gmt":"2025-11-03T14:40:34","slug":"ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/","title":{"rendered":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN DIEGO, Nov.  03, 2025  (GLOBE NEWSWIRE) &#8212; ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Monday, November 10, 2025, at 5:30 a.m. PT \/ 8:30 a.m. ET to discuss its third quarter 2025 financial results and business highlights.<\/p>\n<p>Dial-in information for conference participants may be obtained by <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mZxxdEfhbXY-7sz8sz-F1DdB3Ikf8i1uRniplQqARh0uTAPUyHDE6r6dVunSlDrXFBiotCLEDKuQmX6-6R9fBgS--OrMET-VzACCk5U2buq9-Oa4gJKAk_CWeqkZDPZKA2qtSvEoZS3Uv3swRFw7ADufhag7tb48Cipj1UjJhaQdOJgOH4HKn875D4xdlArT\" rel=\"nofollow\" target=\"_blank\">registering for the event<\/a>. To access the webcast and slides, please visit the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Rak1ykoAUFylrzZcm6ClJaHQyg0byBnt9oVl5bVoi1LzE26AuJl047hVHRBy_nb6dqnv7PJ5zV8ZIgqDs91pmuMw6fUt7A-65T5cpo_Ghf1UvxPkcet8kyjS4EMVXh-PJCrIFG-Mmg6sNGit4lqkhA==\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentations<\/a> page in the Investors &amp; Media section of the Company\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IH17hArAlx7FqAOOf-40lgkwX00XClvABzeYZSa_LkA_05dKVPGzF3SsI8uHXmqrsqTOW4OxxcsTsdipH4cSFg==\" rel=\"nofollow\" target=\"_blank\">website<\/a>. A replay of the webcast will be available for 30 days following the event.<\/p>\n<p>\n        <strong>About ARS Pharmaceuticals, Inc.<\/strong>\n      <\/p>\n<p>ARS Pharma is a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis. The Company is commercializing\u00a0<strong><em>neffy<\/em><\/strong><sup>\u00ae<\/sup>\u00a0(trade name\u00a0<strong>EUR<\/strong><strong><em>neffy<\/em><\/strong><sup>\u00ae<\/sup>\u00a0in the EU), an epinephrine nasal spray indicated in the U.S. for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult and pediatric patients 4 years of age and older who weigh 15 kg or greater, and in the EU for emergency treatment of allergic reactions (anaphylaxis) due to insect stings or bites, foods, medicinal products, and other allergens as well as idiopathic or exercise induced anaphylaxis in adults and children who weigh 30 kg or greater. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hjIT_G1OR7AfUlpAQpHvkGqrEeqQHmqZi6rt4lVEPaKcH_dvY92PZrSCcBJtfcVGrvunhu62grNiKEzOYp0azhbU-_JIGiK3b6CRVRSbNSE=\" rel=\"nofollow\" target=\"_blank\">www.ars-pharma.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Justin Chakma<br \/>ARS Pharmaceuticals<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A-p4Pgh23RFbaYpLmGe3J7enafleTKIAUIejwgLxLJ4gs7guwi9dt2P-9r6DrXvHM4YTFSviTpEYchYMmsUc21ISi2xGJB_Un0ZZX0d61pM=\" rel=\"nofollow\" target=\"_blank\">justinc@ars-pharma.com<\/a><\/p>\n<p>Monique Allaire<br \/>THRUST<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZkfoKkHgWbd-Ij-Dl6AqPW7tVUBqj4iNZXDdUFFcrAxAbeqAY2GriBszeMSxdtIsJ75KGXMMyGEj25SRBjjo8e8hGUiWC2p7CihM4aNT69I=\" rel=\"nofollow\" target=\"_blank\">monique@thrustsc.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Christy Curran<br \/>Sam Brown Inc.<br \/>615.414.8668<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5x7cOV6kk0cunqAcppN0YS6KEHFnMUd11D0YoXIkBlj59FWuIW8jgkT965iLCmQ5RmcH8LGMqOy8zYzJOeNlQScmL-y80OnWJEQqY5klhPe-qesZYuJuF8Zv8qTBIalm\" rel=\"nofollow\" target=\"_blank\">christycurran@sambrown.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjQ5NSM3MjM3NTI2IzIyMDQ5Nzc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTA0Y2FmMzYtMjMyYS00MDY0LTkxODgtNmI4Nzk5NjY1YmYyLTEyMTY1MzAtMjAyNS0xMS0wMy1lbg==\/tiny\/ARS-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Monday, November 10, 2025, at 5:30 a.m. PT \/ 8:30 a.m. ET to discuss its third quarter 2025 financial results and business highlights. Dial-in information for conference participants may be obtained by registering for the event. To access the webcast and slides, please visit the Events &amp; Presentations page in the Investors &amp; Media section of the Company\u2019s website. A replay of the webcast will be available for 30 days following the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904154","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Monday, November 10, 2025, at 5:30 a.m. PT \/ 8:30 a.m. ET to discuss its third quarter 2025 financial results and business highlights. Dial-in information for conference participants may be obtained by registering for the event. To access the webcast and slides, please visit the Events &amp; Presentations page in the Investors &amp; Media section of the Company\u2019s website. A replay of the webcast will be available for 30 days following the &hellip; Continue reading &quot;ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T14:40:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjQ5NSM3MjM3NTI2IzIyMDQ5Nzc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results\",\"datePublished\":\"2025-11-03T14:40:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\\\/\"},\"wordCount\":273,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NjQ5NSM3MjM3NTI2IzIyMDQ5Nzc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\\\/\",\"name\":\"ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NjQ5NSM3MjM3NTI2IzIyMDQ5Nzc=\",\"datePublished\":\"2025-11-03T14:40:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NjQ5NSM3MjM3NTI2IzIyMDQ5Nzc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NjQ5NSM3MjM3NTI2IzIyMDQ5Nzc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results - Market Newsdesk","og_description":"SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Monday, November 10, 2025, at 5:30 a.m. PT \/ 8:30 a.m. ET to discuss its third quarter 2025 financial results and business highlights. Dial-in information for conference participants may be obtained by registering for the event. To access the webcast and slides, please visit the Events &amp; Presentations page in the Investors &amp; Media section of the Company\u2019s website. A replay of the webcast will be available for 30 days following the &hellip; Continue reading \"ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T14:40:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjQ5NSM3MjM3NTI2IzIyMDQ5Nzc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results","datePublished":"2025-11-03T14:40:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/"},"wordCount":273,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjQ5NSM3MjM3NTI2IzIyMDQ5Nzc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/","name":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjQ5NSM3MjM3NTI2IzIyMDQ5Nzc=","datePublished":"2025-11-03T14:40:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjQ5NSM3MjM3NTI2IzIyMDQ5Nzc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjQ5NSM3MjM3NTI2IzIyMDQ5Nzc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-third-quarter-2025-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904154"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904154\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}